Purpose An American Society of Clinical Oncology (ASCO) focused update updates a single
recommendation (or subset of recommendations) in advance of a regularly scheduled …

There is perhaps no other topic that has engendered such controversy and confusion than
that of epidermal growth factor receptor (EGFR) therapy biomarkers. Candidate markers, all …

Background: Maintenance strategy has been used to improve survival in non-small cell lung
cancer (NSCLC). We investigated whether switch maintenance therapy with vinorelbine …

Background The effect of palliative chemotherapy for non-small cell lung cancer (NSCLC) is
well established. Recently, immune checkpoint inhibitors have shown promising efficacy in …

Background The increased availability of active agents has improved overall survival (OS) in
patients with advanced non–small-cell lung cancer (NSCLC). We previously showed that …

Systemic chemotherapy with platinum‐based regimens provides modest improvements in
survival and quality of life for patients with advanced‐stage nonsmall‐cell lung cancer …

Abstract Background Maintenance treatment (MTx) in responders following first-line
treatment has been investigated and practiced for many cancers. Modeling and simulation …

Lung cancer is the most commonly diagnosed cancer amongst men and women combined,
and is responsible for the greatest number of cancer-related deaths worldwide [1]. Non …

Introduction Maintenance therapy in advanced non–small-cell lung cancer (NSCLC) might
lead to resistance to subsequent treatments. IFCT–GFPC 0502 study showed a progression …

则应用 TC 方案进行持续化疗袁直至疾病进展遥 两个试验中袁 大多数患者因治疗相关毒性反应
未能完成长周期化疗遥 DePierre 设计的前瞻性试验虽然未能证明维持化疗在 4 …